Apollo Hospitals to organise 1st International PROTON Therapy Educational Programme
* Eminent internationally renowned specialists to come together to share insights on fighting cancer through PROTON Beam Therapy
Chennai, October 31, 2018: Apollo Hospitals today announced that the APCC (Apollo Proton Cancer Centre) and the PTCOG (Particle Therapy Cooperative Group will be organising the 1st International PROTON Therapy Educational Programme with eminent international specialists coming together to share insights on fighting cancer with PROTON Therapy. The conference will be held over two days with international oncology experts and specialists from across the globe coming together to throw light on various aspects of Proton beam therapy including the technology and its use in the treatment of cancer in clinical practice. Over 400 doctors, physicists and health professionals including from all leading institutions in the country and neighbouring countries would be attending this eagerly awaited conference. Health ministers from South Africa, Oman, Yemen and Sri Lanka are expected to attend this prestigious conference being held for the first time in the country.
Proton Therapy is the most advanced and targeted cancer treatment due to its superior dose distribution and minimal side effects that helps treat cancer more effectively and efficiently. With proton therapy, higher doses of radiation can be used to control and manage cancer while significantly reducing damage to healthy tissue and organs.
The programme faculty will include eminent names including Jay Flanz, PhD, Massachusetts, General Hospital,USA; Eugen Hug, MD, Med Austron, Austria; Tony Lomax, PhD, Paul Scherrer Institute, Switzerland; Håkan Nyström, PhD, Danish Centre for Particle Therapy, Denmark; Ramesh Rengan, MD, Seattle Cancer Care Alliance, USA; Niek Schreuder, PhD, Provision Center forProton Therapy,USA; Damien Weber, MD, Paul Scherrer Institute, Switzerland and Petra Witt Nyström, MD, Danish Centre for Particle Therapy, Denmark and The Skandion Clinic, Sweden.
Dr Rakesh Jalali, Medical Director, Apollo Proton Cancer Centre, Chennai said, “There is a world of difference between standard radiation treatment and proton beam therapy. With standard radiation, healthy tissues are also at the risk of radiation leading to not infrequent and unfortunately frequently irreversible damage. Modern contemporary proton beam therapy such as the one being implemented in Chennai allows highly conformal treatments with ultra-high precision of tumours located in difficult to access areas such as the head & neck, brain, gastro intestinal tract, pelvic tumours such as prostrate as well as in childhood cancers, with minimal normal tissue injury and fewer side effects and is therefore rapidly emerging as standard of care to improve cancer survivals and achieving high quality long-term survivorship. The conference will provide an excellent platform enable physicians to understand this state of the art cancer management and treatment technology that will soon be available to cancer patients in India.”